Lilly Diabetes Launches Mobile App for Type 1 Diabetes Support

Eli Lilly and Company – a venerable name in pharmaceutical products – is behind a new mobile app that serves as a “teaching tool” and can provide guidance for treatment with Lilly Glucagon for Injection.

On Tuesday, Lilly Diabetes announced the release of the new mobile application, which is designed for caregivers and healthcare providers who support people with type 1 diabetes.

The Lilly Glucagon Mobile App is a tool to teach how to use Glucagon for Injection, through simulated practice.

The app is designed to help people be more prepared, and also provide an opportunity to store locations and expiration dates of their Lilly Glucagon Emergency Kits.

“Lilly Diabetes is committed to developing personalized solutions to help people with diabetes achieve their treatment goals and improve their outcomes,” said Matt Caffrey, U.S. Product Brand Director at Lilly Diabetes. “The Lilly Glucagon Mobile App leverages the power and reach of mobile technology, providing another opportunity to support people living with type 1 diabetes. Lilly Diabetes is constantly striving to create new and better tools to support the diabetes community in a variety of ways.”

The Lilly Glucagon Mobile App is now available on the iTunes store as a free download for iPhone or iPad mobile devices.